Healthcare Industry News: DePuy
News Release - January 24, 2008
Softscope Medical Technologies, Inc. Announces the Appointment of John E. Schellhorn as Chief Executive OfficerMINNETONKA, Minn., Jan. 24 (HSMN NewsFeed) -- Softscope Medical Technologies, Inc., an early stage medical device company developing an innovative technology to significantly improve endoscopic procedures, announced today the appointment of John E. Schellhorn as Chief Executive Officer. Mr. Schellhorn has more than 23 years of experience in the medical device field, most recently with ev3 Inc., a global leader in the manufacture of minimally invasive devices to treat vascular disease and disorders.
Prior to his position at ev3 Inc. as Vice President of Sales and Marketing for the Peripheral Vascular Division, Mr. Schellhorn served as International Vice President and General Manager for ACMI Corporation, which was acquired by Gyrus PLC in 2005. Prior to ACMI Corporation, he was Vice President of Sales for DePuy AcroMed, a division of Johnson & Johnson, and spent seven years with Boston Scientific in positions including Director of Sales and Marketing, Asia/Pacific; General Manager, Australia; and Vice President of Sales for the Microvasive Urology Division.
Kathy Tune, a Softscope director with Thomas, McNerney & Partners stated, "John brings a proven track record of sales and marketing expertise in the medical device field. His leadership abilities and industry knowledge will be a tremendous asset to the Company as it continues development of its first product to improve endoscopic procedures."
"The board and the team are delighted that John has joined us at this exciting time in the Company's development," said John Deedrick, a Softscope director with Accuitive Medical Ventures. "His experience with successfully launching endoscopic medical devices will be valuable as the Company seeks FDA clearance and commercializes its innovative endoscopic technologies."
About Softscope Medical Technologies, Inc.
Softscope Medical Technologies, Inc., founded in 2003, is a privately-owned, pre-clinical stage medical device company headquartered in Minnetonka, MN. Softscope is focused on developing an innovative medical technology designed to significantly improve the performance of endoscopic equipment. The Company's products are not currently offered for sale in any country.
Source: Softscope Medical Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.